admission date:  [2140-3-24]              discharge date:   [2140-4-4]date of birth:  [2056-8-22]             sex:   fservice: surgeryallergies:demerol / droperidol / penicillamine / streptomycin / ampicillinattending:[first name3 (lf) 1]chief complaint:abdominal painmajor surgical or invasive procedure:exploratory laparotomy, extensive lysis of adhesions, smallbowel resection with reanastomosis, repair recurrent ventralhernia.history of present illness:mrs. [known lastname 104299] is an 83yo female with [hospital 10224] medical and surgicalproblems. she has a known h/o recurrent ventral hernia. shepresented to [hospital1 18] ed with complaints of abdominal pain, n/v x 3hours. she reported the pain to be similar to the prior painthat she had with previous small bowel obstructions. she lastreports passing flatus the night before presentation to the ed,but no flatus since. she was admitted to the surgery service forfurther evaluation..during work-up in ed, the patient was found to have a prolongedqt interval near 600. of note, patient had dose of flecaniderecently increased. she was also hypokalemic, kcl down to 2.9 onpresentationpast medical history:hyperlipidemia: [8-/2139] ldl 114 hdl 73 chol 209 tg 108hypertension, labile blood pressurediastolic left ventricular dysfunction with ef >55%renal insufficiency: egfr 50 stage 3a (most likely [1-25] htn)chronic chest pain, clean coronary arteries by [2127]catheterizationparoxysmal afibesophageal spasmgoutgastroesophageal reflux diseasestatus tah-bso in [2121] for menorrhagia.chronic vaginal itching, now on premarin cream.small bowel obstruction in [2123], [2126] and [2138] s/p adhesionlysis in [9-/2139]migraine headachesh/o hysterectomy (abdominal)h/o abdominal hernia with repairgallstonessocial history:social history is significant for the absence of current tobaccouse and patient states she has never smoked. there is no historyof alcohol abuse or illegal substance use. patient lives in[location 583], ma. she is a retired dentist and immigrated from[country 532] and [location (un) 3156] in the [2110].family history:there is no family history of premature coronary artery diseaseor sudden death.  [name (ni) ] mother had htn.physical exam:at discharge:vitals:gen: nad, a/ox3cv: rrr, no m/r/gresp: ctab, decreased bases bilaterally. no w/r/rabd: soft slightly distended, appropriately ttpincision: midline abdominal ota with staples, mild erythema atstaples sites with scant dry blood, otherwise cdigi/gu: diaper in place due to urinary frequency/incontinence.rectal tube placed on [2140-4-2] for frequent loose brown stool.intact. no rectal irritation/excoriation notedskin: perineal skin free of rash and excoriationextrem: b/l 1+ pedal edema. +dp'spertinent results:[2140-3-23] 09:05pm blood wbc-8.1 rbc-4.22 hgb-11.8 hct-34.4mcv-81 mch-27.9 mchc-34.2 rdw-15.5 plt ct-201[2140-3-25] 04:43am blood wbc-7.7 rbc-3.74 hgb-10.6 hct-31.1mcv-83 mch-28.3 mchc-34.1 rdw-15.9 plt ct-153[2140-3-27] 04:11am blood wbc-11.2# rbc-3.84# hgb-10.9#hct-33.2# mcv-87 mch-28.5 mchc-32.9 rdw-15.2 plt ct-175[2140-3-29] 02:18am blood wbc-8.5 rbc-3.11 hgb-9.0 hct-27.3mcv-88 mch-28.9 mchc-32.9 rdw-15.3 plt ct-175[2140-4-1] 04:49am blood wbc-7.0 rbc-3.13 hgb-8.7 hct-26.7mcv-85 mch-27.6 mchc-32.4 rdw-15.3 plt ct-195[2140-4-3] 03:34am blood wbc-10.2 rbc-3.49 hgb-9.8 hct-28.6mcv-82 mch-28.0 mchc-34.2 rdw-15.7 plt ct-255[2140-4-4] 05:50am blood wbc-12.0 rbc-3.75 hgb-10.2 hct-30.9mcv-83 mch-27.2 mchc-33.0 rdw-15.9 plt ct-318[2140-3-23] 09:05pm blood pt-32.3 ptt-35.4 inr(pt)-3.4[2140-3-25] 04:43am blood pt-42.0 ptt-44.0 inr(pt)-4.6[2140-3-26] 06:20pm blood pt-18.1 ptt-35.0 inr(pt)-1.7[2140-3-27] 12:40am blood pt-17.3 ptt-32.7 inr(pt)-1.6[2140-3-28] 02:03am blood pt-15.7 ptt-37.3 inr(pt)-1.4[2140-3-23] 09:05pm blood glucose-109 urean-77 creat-2.1 na-137k-2.9 cl-90 hco3-33 angap-17[2140-3-24] 08:51pm blood glucose-118 urean-65 creat-1.6 na-144k-4.0 cl-105 hco3-28 angap-15[2140-3-26] 02:25am blood glucose-104 urean-41 creat-1.1 na-150k-3.3 cl-109 hco3-32 angap-12[2140-3-28] 03:29pm blood glucose-106 urean-31 creat-1.1 na-152k-3.7 cl-114 hco3-31 angap-11[2140-3-29] 02:18am blood glucose-105 urean-29 creat-1.0 na-153k-3.7 cl-116 hco3-30 angap-11[2140-3-29] 12:46pm blood glucose-128 urean-27 creat-0.9 na-152k-3.8 cl-116 hco3-28 angap-12[2140-4-2] 04:03am blood glucose-94 urean-17 creat-0.8 na-141k-3.5 cl-104 hco3-29 angap-12[2140-4-3] 06:53am blood glucose-80 urean-16 creat-0.7 na-141k-3.5 cl-103 hco3-30 angap-12[2140-4-4] 05:50am blood glucose-101 urean-12 creat-0.8 na-140k-4.2 cl-104 hco3-28 angap-12[2140-3-23] 09:05pm blood albumin-4.1[2140-3-24] 04:30am blood calcium-8.5 phos-6.2# mg-2.4[2140-3-24] 08:51pm blood calcium-8.1 phos-4.7 mg-3.2[2140-3-27] 12:13pm blood calcium-8.5 phos-2.6 mg-2.1[2140-3-28] 02:03am blood calcium-8.4 phos-3.9 mg-2.4[2140-3-28] 03:29pm blood calcium-8.3 phos-4.2 mg-2.5[2140-4-2] 04:03am blood calcium-7.8 phos-2.9 mg-2.0[2140-4-3] 06:53am blood calcium-7.7 phos-3.4 mg-1.8[2140-4-4] 05:50am blood calcium-7.9 phos-3.8 mg-2.2.cdiff culture negative x 2 on [4-3] & [2140-4-4].mrsa culture negative x 2 on [3-24] & [2140-3-26].urine culture negative on [2140-3-23].ct abdomen w/o contrast study date of [2140-3-24] 12:43 amimpression:1. findings consistent with small bowel obstruction at the levelof theventral abdominal wall outpouching (likely attenuation ofperitoneum rather than true hernia), with distal decompression.no perforation.2. cholelithiasis without cholecystitis.3. atherosclerotic calcification..pathology examinationprocedure date     [2140-3-26]diagnosis:small bowel, segmental resection:segment of small bowel with fibrous adhesions, one incorporatingsynthetic mesh material, and focus of ischemic necrosis.tissue at margins appears viable.clinical:  bowel obstruction..chest (pa & lat) study date of [2140-3-31] 4:16 pmimpression: new left perihilar region faint ground-glass opacityconcerning for aspiration. persistent bibasilar atelectasis withbilateral pleural effusions..[2140-4-1]-video swallow completed via ct scanbrief hospital course:mrs. [known lastname 104299] was underwent a ct scan in the ed for c/o abdominalpain. her ct scan revealed a small bowel obstruction near herknown ventral hernia which was reducible at the beside. generalsurgery was consulted, and she was admitted to the icu found tohave junctional brady rhythm with prolonged qt (qtc near 600) incontext of recent increase in flecainide dose per pcp. [name10 (nameis) ] wasmonitored in the icu for a few days. cardiology was consulted,and recommended holding beta blocker, and flecanide. coumadinwas also held in case of need for surgical intervention. inaddition, her potassium of 2.9 and magnesium were aggressivelyrepleted. her cardiac status stabilized after undergoingdiuresis with diamox, however, her abdominal exam worsened overthe following 48 hours after a few days of conservativemanagement with npo/ngt for decompression and iv antibiotics..she was taken to the or, and underwent lysis of adhesions andsmall bowel resection.her operative course was uncomplicated, routinely observed inthe pacu, and transferred back to [hospital unit name 153] where cardiac monitoringand electrolyte correction occurred. she was transfused post/opwith 2 u prbc. hcts remained stable thereafter. she wasextubated and wean off pressors, and transferred to stone 5..physical therapy was consulted upon transfer to stone 5 forexpected discharge to rehab due to physical deconditioning.remained npo until bowel function resumed. electrolytes checkedand repleted daily. hyponatremia resolved gradually. started onsips of water, advanced to clear liquids. noted to havedifficulty swallowing and clearing secretions. bedside swallowstudy conducted. she was taken for video swallow, and clearedfor regular diet with thick liquids, and whole pills in puree.patient reported passing flatus, and incontinent of loose, brownstools. rectal tube inserted on [2140-4-2] due to frequencey ofbowel movements, and risk for compromise of perineal skin.rectal tube should be removed by friday [2140-4-8] to preventrectal breakdown. diet advanced to regular food. reportedintermittent nausea and lack of appetite which has persistedthroughout post-op recovery.  foley was removed. she was able tourinate, incontinent of urine. ua and urine cultures negative..mobility compromised. she requires [1-26] people for ambulation andtransfer. requires aggressive physical rehab, and monitoring ofnutritional, bowel, and cardiac status. she should follow-upwith pcp (dr. [first name8 (namepattern2) ] [last name (namepattern1) 2450]), and cardiology to address cardiacevents (prolonged qt interval) during this admission. [hospital 197]clinic at [hospital1 18] manages the patients coumadin dosing for paf.coumadin 2mg po given at [2140-4-4]. inr should be checked on[2140-4-5], and daily until therapeutic. goal inr [1-26]..she will require to have the incisional staples removed inanother week. this can be done per rehab facility afterauthorization per dr. [last name (stitle) ] (surgeon).medications on admission:allopurinol 100', lipitor 20', colchicine prn, diltsr 240',flonase 50", lasix 80", diazepam 5 prn, gabapentin600hs/300am/300pmhydralazine 50 tid, toprolxl 100 daily, nitroglycerin prn,prilosec 40 daily, zoloft 100', spironolactone 25', asa 81',coumadin 1mgmwf 2mg other daysdischarge medications:1. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewablepo daily (daily).2. calcium carbonate 500 mg tablet, chewable sig: two (2)tablet, chewable po q 12h (every 12 hours).3. hydromorphone 2 mg tablet sig: 1-2 tablets po q4h (every 4hours) as needed for breakthrough for 2 weeks.4. atorvastatin 20 mg tablet sig: one (1) tablet po daily(daily).5. allopurinol 100 mg tablet sig: one (1) tablet po daily(daily).6. colchicine 0.6 mg tablet sig: one (1) tablet po daily (daily)as needed for gout flare/pain.7. diltiazem hcl 240 mg capsule, sustained release sig: one (1)capsule, sustained release po daily (daily).8. fluticasone 50 mcg/actuation spray, suspension sig: one (1)spray nasal [hospital1 ] (2 times a day).9. furosemide 80 mg tablet sig: one (1) tablet po bid (2 times aday).10. diazepam 5 mg tablet sig: one (1) tablet po q6h (every 6hours) as needed for anxiety.11. gabapentin 300 mg capsule sig: one (1) capsule po q12h(every 12 hours).12. gabapentin 300 mg capsule sig: two (2) capsule po hs (atbedtime).13. hydralazine 50 mg tablet sig: one (1) tablet po tid (3 timesa day).14. metoprolol succinate 100 mg tablet sustained release 24 hrsig: one (1) tablet sustained release 24 hr po daily (daily).15. omeprazole 20 mg capsule, delayed release(e.c.) sig: two (2)capsule, delayed release(e.c.) po daily (daily).16. sertraline 100 mg tablet sig: one (1) tablet po daily(daily).17. spironolactone 25 mg tablet sig: one (1) tablet po daily(daily).18. acetaminophen 325 mg tablet sig: two (2) tablet po q6h(every 6 hours) as needed for fever or pain for 2 weeks: do notexceed 4000mg in 24hrs.19. coumadin 1 mg tablet sig: titrate dose per inr tablet poonce a day: goal inr [1-26]. usual dosing mwf-1mg,other days 2mg.20. metronidazole 500 mg tablet sig: one (1) tablet po q8h(every 8 hours) for 5 days.21. zofran 2 mg/ml solution sig: two (2)  intravenous everyeight (8) hours as needed for nausea for 1 weeks.discharge disposition:extended carefacility:[hospital6 459] for the aged - [location (un) 550]discharge diagnosis:primary:pre/op prolonged qt interval-managed in icu & cardiologyconsultedrecurrent incisional hernia reduced intestinepost-op dysphagia-evaluated per speech & swallow specialistpost-op blood loss anemia.secondary:hx of sbox3, hchol, htn, labile blood pressure,[last name (un) 6043] lv dysfn,cri, chronic chest pain, paroxysmal afib, esoph spasm, gout,gerd, migraines, gall stonesdischarge condition:stabletolerating a regular diet with ensure supplements.tolerating oral medications, whole, if purees.adequate pain control with oral medication.discharge instructions:for rehab:weigh patient every morning, [name8 (md) 138] md if weight > 3 lbs.adhere to 2 gm sodium dietfluid restriction: none. contact pcp, [last name (namepattern4) ]. [first name8 (namepattern2) ] [last name (namepattern1) 2450], with anyconcerns..please call dr. [last name (stitle) ] or return to the er for any of thefollowing: you experience new chest pain, pressure, squeezing ortightness. new or worsening cough or wheezing. if you are vomiting and cannot keep in fluids or yourmedications. you are getting dehydrated due to continued vomiting,diarrhea or other reasons. signs of dehydration include drymouth, rapid heartbeat or feeling dizzy or faint when standing. you see blood or dark/black material when you vomit or have abowel movement. your pain is not improving within 8-12 hours or not gonewithin 24 hours. call or return immediately if your pain isgetting worse or is changing location or moving to your chest orback.avoid lifting objects > 5lbs until your follow-up appointmentwith the surgeon.avoid driving or operating heavy machinery while taking painmedications. you have shaking chills, or a fever greater than 101.5 (f)degrees or 38(c) degrees. any serious change in your symptoms, or any new symptoms thatconcern you. continue to ambulate several times per day..incision care:-your staples will be removed at your follow-up appointment withdr. [last name (stitle) ]. staples may be removed at rehab facilit. pleasecontact dr.[name (ni) 10946] office to authorize removal. steristrips will be applied.-your steri-strips will fall off on their own. please remove anyremaining strips 7-10 days after surgery.-you may shower, and wash surgical incisions.-avoid swimming and baths until your follow-up appointment.-please call the doctor if you have increased pain, swelling,redness, or drainage from the incision sites..medications:1. coumadin: continue to dose patient daily according to inrlevel. goal inr [1-26]. usual home dosing is 1 mg mwf, and 2mgother days of week. patient is followed per [hospital 18] [hospital 197]clinic.followup instructions:1. please follow-up with dr. [last name (stitle) ] [telephone/fax (1) 9] in [12-25]weeks for removal of staples.2. follow-up with pcp, [last name (namepattern4) ]. [first name8 (namepattern2) ] [last name (namepattern1) 2450], [telephone/fax (1) 250], 1-2 weeksafter discharge from rehab.3. follow-up with [hospital 197] clinic([telephone/fax (1) 10844]-[hospital1 18][location (un) 86]-after discharge from rehab for continued management ofcoumadin..previous appointments:1. provider: [name initial (nameis) 703] (h3) general 2 [name initial (nameis) 706] phone:[telephone/fax (1) 327]date/time:[2140-4-5] 9:302. provider: [name10 (nameis) 706] phone:[telephone/fax (1) 327] date/time:[2140-4-7]8:003. provider: [name10 (nameis) 706] phone:[telephone/fax (1) 327] date/time:[2140-4-7]8:15completed by:[2140-4-4]